Biotechnology in Italy
Biotechnology in Italy
SUMMARY
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Italian biotechnology market had total revenues of $13.5bn in 2019, representing a compound annual growth rate (CAGR) of 11.8% between 2015 and 2019.
- The medical/healthcare segment was the market's most lucrative in 2019, with total revenues of $5.6bn, equivalent to 41.7% of the market's overall value.
- Compared with pharmas, biotech companies will have more difficulty compensating for supply chain disruptions from COVID-19, due to the high costs associated with their RandD.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Italy
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts
- What was the size of the Italy biotechnology market by value in 2019?
- What will be the size of the Italy biotechnology market in 2024?
- What factors are affecting the strength of competition in the Italy biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Italy's biotechnology market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Do any leading players have notable weaknesses?
7.4. How might COVID-19 affect the competitive landscape?
8 COMPANY PROFILES
8.1. A Menarini Industrie Farmaceutiche Riunite Srl
8.2. Zambon Co SpA
8.3. Jazz Pharmaceuticals Plc
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Do any leading players have notable weaknesses?
7.4. How might COVID-19 affect the competitive landscape?
8 COMPANY PROFILES
8.1. A Menarini Industrie Farmaceutiche Riunite Srl
8.2. Zambon Co SpA
8.3. Jazz Pharmaceuticals Plc
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Italy biotechnology industry value: $ billion, 2015-19
Table 2: Italy biotechnology industry category segmentation: $ billion, 2019
Table 3: Italy biotechnology industry geography segmentation: $ billion, 2019
Table 4: Italy biotechnology industry value forecast: $ billion, 2019-24
Table 5: A Menarini Industrie Farmaceutiche Riunite Srl: key facts
Table 6: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees
Table 7: Zambon Co SpA: key facts
Table 8: Zambon Co SpA: Key Employees
Table 9: Jazz Pharmaceuticals Plc: key facts
Table 10: Jazz Pharmaceuticals Plc: Annual Financial Ratios
Table 11: Jazz Pharmaceuticals Plc: Key Employees
Table 12: Italy size of population (million), 2015-19
Table 13: Italy gdp (constant 2005 prices, $ billion), 2015-19
Table 14: Italy gdp (current prices, $ billion), 2015-19
Table 15: Italy inflation, 2015-19
Table 16: Italy consumer price index (absolute), 2015-19
Table 17: Italy exchange rate, 2015-19
Table 1: Italy biotechnology industry value: $ billion, 2015-19
Table 2: Italy biotechnology industry category segmentation: $ billion, 2019
Table 3: Italy biotechnology industry geography segmentation: $ billion, 2019
Table 4: Italy biotechnology industry value forecast: $ billion, 2019-24
Table 5: A Menarini Industrie Farmaceutiche Riunite Srl: key facts
Table 6: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees
Table 7: Zambon Co SpA: key facts
Table 8: Zambon Co SpA: Key Employees
Table 9: Jazz Pharmaceuticals Plc: key facts
Table 10: Jazz Pharmaceuticals Plc: Annual Financial Ratios
Table 11: Jazz Pharmaceuticals Plc: Key Employees
Table 12: Italy size of population (million), 2015-19
Table 13: Italy gdp (constant 2005 prices, $ billion), 2015-19
Table 14: Italy gdp (current prices, $ billion), 2015-19
Table 15: Italy inflation, 2015-19
Table 16: Italy consumer price index (absolute), 2015-19
Table 17: Italy exchange rate, 2015-19
LIST OF FIGURES
Figure 1: Italy biotechnology industry value: $ billion, 2015-19
Figure 2: Italy biotechnology industry category segmentation: % share, by value, 2019
Figure 3: Italy biotechnology industry geography segmentation: % share, by value, 2019
Figure 4: Italy biotechnology industry value forecast: $ billion, 2019-24
Figure 5: Forces driving competition in the biotechnology industry in Italy, 2019
Figure 6: Drivers of buyer power in the biotechnology industry in Italy, 2019
Figure 7: Drivers of supplier power in the biotechnology industry in Italy, 2019
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Italy, 2019
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Italy, 2019
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Italy, 2019
Figure 1: Italy biotechnology industry value: $ billion, 2015-19
Figure 2: Italy biotechnology industry category segmentation: % share, by value, 2019
Figure 3: Italy biotechnology industry geography segmentation: % share, by value, 2019
Figure 4: Italy biotechnology industry value forecast: $ billion, 2019-24
Figure 5: Forces driving competition in the biotechnology industry in Italy, 2019
Figure 6: Drivers of buyer power in the biotechnology industry in Italy, 2019
Figure 7: Drivers of supplier power in the biotechnology industry in Italy, 2019
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Italy, 2019
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Italy, 2019
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Italy, 2019
